1.A Comparative Study on Food Habits and Nutrient Intakes with Body Mass Index of Hypertensive Patients commuting to a Local Health Center.
Journal of the Korean Dietetic Association 2002;8(2):185-198
The purpose of this study was to compare food habits and nutrient intakes with body mass index of hypertensive patients commuting to a Local Health Center. A total of 85 patients were divided into two groups according to BMI. The non-obese group comprised 43 subjects with BMI below 25kg/m2, while the obese group comprised 42 subjects with BMI above 25kg/m2. All Subjects were interviewed for general characteristics, food habits, clinical characteristics, effort for health maintenance and the knowledge of hypertension and nutrition. Anthropometric assessments such as weight, height, waist-hip ratio and biochemical measurement of blood urea nitrogen, creatinine, triglyceride, total cholesterol, HDL-cholesterol and fasting blood glucose(FBG) were obtained from subjects. In general characteristics, smoking, drinking, exercise, and hypertension status were not significantly different between the two groups. Food habits and the means of daily energy and nutrients were not significantly different between the two groups. An analysis of the percentage of RDA(Recommended Dietary Allowances of Korea, 2000) consumed by patients showed that but for ascorbic acid and phosphorus, all nutrients were below the RDA. And intakes of vitamin B1(P<0.001), vitamin B2(P<0.01), niacin(P<0.001) of the obese group were significantly lower than that of the non-obese group. Blood urea nitrogen, creatinine, triglyceride, total cholesterol, HDL-cholesterol and fasting blood glucose were in the normal range and there was not a significant difference in the two groups. Therefore, more effective nutrition education programs about exercise, smoking, caloric intake, vitamins and minerals are required for hypertensive patients commuting to Local Health Center.
Ascorbic Acid
;
Blood Glucose
;
Blood Urea Nitrogen
;
Body Mass Index*
;
Cholesterol
;
Creatinine
;
Drinking
;
Education
;
Energy Intake
;
Fasting
;
Food Habits*
;
Humans
;
Hypertension
;
Korea
;
Minerals
;
Obesity
;
Phosphorus
;
Reference Values
;
Smoke
;
Smoking
;
Transportation*
;
Triglycerides
;
Vitamins
;
Waist-Hip Ratio
2.Field evaluation of the safety and immunogenicity of a classical swine fever virus E2 subunit vaccine in breeding and nursery animals on Jeju Island, South Korea
Guehwan JANG ; Eun-Joo KIM ; Seong-Cheol CHO ; Sung-Up MOON ; Byeong Soo KIM ; Jinhee KIM ; Kyoung Ju JEONG ; Kyungok SONG ; Seong Hwan MUN ; Won-Myoung KANG ; Jonghoo LEE ; Changnam PARK ; Hyoung-Seok YANG ; Changhee LEE
Clinical and Experimental Vaccine Research 2022;11(3):264-273
Purpose:
Classical swine fever (CSF) reemerged on CSF-free Jeju Island where vaccination is not practiced by the unintentional injection of a live attenuated vaccine (modified live attenuated vaccines–low-virulence Miyagi [MLV-LOM]) in 2014. Since the Jeju provincial authority is considering adopting a voluntary immunization policy using a CSF-E2 subunit vaccine to combat LOM-derived CSF endemic, this study aimed to evaluate in Jeju herds.
Materials and Methods:
Two vaccination trials using the Bayovac CSF-E2 vaccine licensed for use in South Korea assessed the safety and humoral immunity of the CSF-E2 vaccine in breeding (trial 1) and nursery animals (trial 2) under farm application conditions.
Results:
Neither local nor systemic (including reproductive) adverse effects were objectively observed in pregnant sows and young piglets following a respective vaccination regime at pregnancy or weaning, respectively. Trial 1 showed that sows immunized with the CSF-E2 vaccine possessed high and consistent E2-specific and neutralizing antibody levels. The CSF-E2 vaccine-immunized pregnant sows subsequently conferred appropriate and steady passive immunity to their offspring. In trial 2, a double immunization scheme of the CSF-E2 vaccine in piglets at 40 and 60 days of age could elicit a consistent and long-lasting adequate antibody response. Additionally, the two trials detected no E rns -specific antibody responses, indicating that CSF-E2 vaccine can differentiate infected from vaccinated animals (DIVA).
Conclusion
Our trial data collectively provide invaluable information on applying the CSFE2 subunit vaccine to circumvent the possible drawbacks associated with the MLV-LOM concerning the safety, efficacy, and DIVA, in the LOM-endemic field farms and contribute to advanced CSF eradication on Jeju Island.